Keyphrases
Bone Turnover Markers
100%
Patients with Prostate Cancer
100%
Potential Correlation
100%
Bone Metastasis
66%
Disease Progression
66%
Disease Response
66%
Denosumab
33%
Zoledronic Acid
33%
Skeletal-related Events
33%
Bone Alkaline Phosphatase
33%
Metastasis Sites
33%
Prostate Cancer
33%
Acid Treatment
33%
Similarity Data
33%
N-telopeptide of Type I Collagen
33%
Unmet Needs
33%
Monitoring Method
33%
Bone Health
33%
Bone Pain
33%
Bone Scan
33%
Osteoblastic Lesions
33%
Bone Disease
33%
Treatment Information
33%
Bone-directed Therapy
33%
Death Rate
33%
Early Change
33%
Ongoing Clinical Trials
33%
Skeletal Homeostasis
33%
Prostate Cancer Metastasis
33%
Investigational Agents
33%
BIOCHEMICAL MARKERS OF BONE TURNOVER
33%
Medicine and Dentistry
Prostate Cancer
100%
Metastatic Carcinoma
50%
Bone Metastasis
50%
Disease Exacerbation
50%
Clinical Trial
25%
Denosumab
25%
Zoledronic Acid
25%
Bone Turnover
25%
Bone Disease
25%
Telopeptide
25%
Collagen Type 1
25%
Skeleton
25%
Bone Pain
25%
Bone Scintigraphy
25%
Alkaline Phosphatase
25%
Biochemical Marker
25%
Skeletal Homeostasis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Bone Metastasis
50%
Disease Exacerbation
50%
Metastasis
25%
Zoledronic Acid
25%
Clinical Trial
25%
Denosumab
25%
Telopeptide
25%
Alkaline Phosphatase
25%
Collagen Type 1
25%
Bone Disease
25%
Bone Pain
25%
Biochemical Marker
25%